Copyright Reports & Markets. All rights reserved.

Global Gastrointestinal Cancer Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Gastrointestinal Cancer Drugs Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Oncology
      • 1.2.2 Radiology
      • 1.2.3 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospitals
      • 1.3.2 Specialized Cancer Treatment Centers
      • 1.3.3 Clinics
      • 1.3.4 Ambulatory Surgical Centers
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2013-2023)
        • 1.4.1.2 Canada Market States and Outlook (2013-2023)
        • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2013-2023)
        • 1.4.2.2 France Market States and Outlook (2013-2023)
        • 1.4.2.3 UK Market States and Outlook (2013-2023)
        • 1.4.2.4 Russia Market States and Outlook (2013-2023)
        • 1.4.2.5 Italy Market States and Outlook (2013-2023)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2013-2023)
        • 1.4.3.2 Japan Market States and Outlook (2013-2023)
        • 1.4.3.3 Korea Market States and Outlook (2013-2023)
        • 1.4.3.4 India Market States and Outlook (2013-2023)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
        • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
        • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
        • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Amgen Limited & Amgen Ireland Limited
      • 2.1.1 Business Overview
      • 2.1.2 Gastrointestinal Cancer Drugs Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.2 Bristol-Myers Squibb Company
      • 2.2.1 Business Overview
      • 2.2.2 Gastrointestinal Cancer Drugs Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.3 F. Hoffmann-La Roche Ltd.
      • 2.3.1 Business Overview
      • 2.3.2 Gastrointestinal Cancer Drugs Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.4 Eli Lilly and Company
      • 2.4.1 Business Overview
      • 2.4.2 Gastrointestinal Cancer Drugs Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.5 Johnson & Johnson Private Limited
      • 2.5.1 Business Overview
      • 2.5.2 Gastrointestinal Cancer Drugs Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.6 GlaxoSmithKline plc.
      • 2.6.1 Business Overview
      • 2.6.2 Gastrointestinal Cancer Drugs Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 GlaxoSmithKline plc. Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.7 Celgene Corporation
      • 2.7.1 Business Overview
      • 2.7.2 Gastrointestinal Cancer Drugs Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Celgene Corporation Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.8 Pfizer Inc.
      • 2.8.1 Business Overview
      • 2.8.2 Gastrointestinal Cancer Drugs Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Pfizer Inc. Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.9 Sanofi
      • 2.9.1 Business Overview
      • 2.9.2 Gastrointestinal Cancer Drugs Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Sanofi Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.10 Novartis AG
      • 2.10.1 Business Overview
      • 2.10.2 Gastrointestinal Cancer Drugs Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Novartis AG Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    3 Global Gastrointestinal Cancer Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Gastrointestinal Cancer Drugs Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Gastrointestinal Cancer Drugs Manufacturer Market Share in 2017
      • 3.3.2 Top 6 Gastrointestinal Cancer Drugs Manufacturer Market Share in 2017
    • 3.4 Market Competition Trend

    4 Global Gastrointestinal Cancer Drugs Market Analysis by Regions

    • 4.1 Global Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Gastrointestinal Cancer Drugs Sales and Market Share by Regions (2013-2018)
      • 4.1.2 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Regions (2013-2018)
    • 4.2 North America Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 4.3 Europe Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 4.4 Asia-Pacific Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 4.5 South America Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 4.6 Middle East and Africa Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)

    5 North America Gastrointestinal Cancer Drugs by Countries

    • 5.1 North America Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Countries
      • 5.1.1 North America Gastrointestinal Cancer Drugs Sales and Market Share by Countries (2013-2018)
      • 5.1.2 North America Gastrointestinal Cancer Drugs Revenue and Market Share by Countries (2013-2018)
    • 5.2 United States Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 5.3 Canada Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 5.4 Mexico Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)

    6 Europe Gastrointestinal Cancer Drugs by Countries

    • 6.1 Europe Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Countries
      • 6.1.1 Europe Gastrointestinal Cancer Drugs Sales and Market Share by Countries (2013-2018)
      • 6.1.2 Europe Gastrointestinal Cancer Drugs Revenue and Market Share by Countries (2013-2018)
    • 6.2 Germany Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 6.3 UK Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 6.4 France Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 6.5 Russia Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 6.6 Italy Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)

    7 Asia-Pacific Gastrointestinal Cancer Drugs by Countries

    • 7.1 Asia-Pacific Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Countries
      • 7.1.1 Asia-Pacific Gastrointestinal Cancer Drugs Sales and Market Share by Countries (2013-2018)
      • 7.1.2 Asia-Pacific Gastrointestinal Cancer Drugs Revenue and Market Share by Countries (2013-2018)
    • 7.2 China Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 7.3 Japan Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 7.4 Korea Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 7.5 India Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 7.6 Southeast Asia Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)

    8 South America Gastrointestinal Cancer Drugs by Countries

    • 8.1 South America Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Countries
      • 8.1.1 South America Gastrointestinal Cancer Drugs Sales and Market Share by Countries (2013-2018)
      • 8.1.2 South America Gastrointestinal Cancer Drugs Revenue and Market Share by Countries (2013-2018)
    • 8.2 Brazil Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 8.3 Argentina Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 8.4 Colombia Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)

    9 Middle East and Africa Gastrointestinal Cancer Drugs by Countries

    • 9.1 Middle East and Africa Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Countries
      • 9.1.1 Middle East and Africa Gastrointestinal Cancer Drugs Sales and Market Share by Countries (2013-2018)
      • 9.1.2 Middle East and Africa Gastrointestinal Cancer Drugs Revenue and Market Share by Countries (2013-2018)
    • 9.2 Saudi Arabia Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 9.3 UAE Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 9.4 Egypt Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 9.5 Nigeria Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
    • 9.6 South Africa Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)

    10 Global Gastrointestinal Cancer Drugs Market Segment by Type

    • 10.1 Global Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Type (2013-2018)
      • 10.1.1 Global Gastrointestinal Cancer Drugs Sales and Market Share by Type (2013-2018)
      • 10.1.2 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Type (2013-2018)
    • 10.2 Oncology Sales Growth and Price
      • 10.2.1 Global Oncology Sales Growth (2013-2018)
      • 10.2.2 Global Oncology Price (2013-2018)
    • 10.3 Radiology Sales Growth and Price
      • 10.3.1 Global Radiology Sales Growth (2013-2018)
      • 10.3.2 Global Radiology Price (2013-2018)
    • 10.4 Others Sales Growth and Price
      • 10.4.1 Global Others Sales Growth (2013-2018)
      • 10.4.2 Global Others Price (2013-2018)

    11 Global Gastrointestinal Cancer Drugs Market Segment by Application

    • 11.1 Global Gastrointestinal Cancer Drugs Sales Market Share by Application (2013-2018)
    • 11.2 Hospitals Sales Growth (2013-2018)
    • 11.3 Specialized Cancer Treatment Centers Sales Growth (2013-2018)
    • 11.4 Clinics Sales Growth (2013-2018)
    • 11.5 Ambulatory Surgical Centers Sales Growth (2013-2018)

    12 Gastrointestinal Cancer Drugs Market Forecast (2018-2023)

    • 12.1 Global Gastrointestinal Cancer Drugs Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Gastrointestinal Cancer Drugs Market Forecast by Regions (2018-2023)
      • 12.2.1 North America Gastrointestinal Cancer Drugs Market Forecast (2018-2023)
      • 12.2.2 Europe Gastrointestinal Cancer Drugs Market Forecast (2018-2023)
      • 12.2.3 Asia-Pacific Gastrointestinal Cancer Drugs Market Forecast (2018-2023)
      • 12.2.4 South America Gastrointestinal Cancer Drugs Market Forecast (2018-2023)
      • 12.2.5 Middle East and Africa Gastrointestinal Cancer Drugs Market Forecast (2018-2023)
    • 12.3 Gastrointestinal Cancer Drugs Market Forecast by Type (2018-2023)
      • 12.3.1 Global Gastrointestinal Cancer Drugs Sales Forecast by Type (2018-2023)
      • 12.3.2 Global Gastrointestinal Cancer Drugs Market Share Forecast by Type (2018-2023)
    • 12.4 Gastrointestinal Cancer Drugs Market Forecast by Application (2018-2023)
      • 12.4.1 Global Gastrointestinal Cancer Drugs Sales Forecast by Application (2018-2023)
      • 12.4.2 Global Gastrointestinal Cancer Drugs Market Share Forecast by Application (2018-2023)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems.

      Scope of the Report:
      This report focuses on the Gastrointestinal Cancer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
      The worldwide market for Gastrointestinal Cancer Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

      Market Segment by Manufacturers, this report covers
      Amgen Limited & Amgen Ireland Limited
      Bristol-Myers Squibb Company
      F. Hoffmann-La Roche Ltd.
      Eli Lilly and Company
      Johnson & Johnson Private Limited
      GlaxoSmithKline plc.
      Celgene Corporation
      Pfizer Inc.
      Sanofi
      Novartis AG

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Oncology
      Radiology
      Others

      Market Segment by Applications, can be divided into
      Hospitals
      Specialized Cancer Treatment Centers
      Clinics
      Ambulatory Surgical Centers

      There are 15 Chapters to deeply display the global Gastrointestinal Cancer Drugs market.
      Chapter 1, to describe Gastrointestinal Cancer Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
      Chapter 2, to analyze the top manufacturers of Gastrointestinal Cancer Drugs, with sales, revenue, and price of Gastrointestinal Cancer Drugs, in 2016 and 2017;
      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
      Chapter 4, to show the global market by regions, with sales, revenue and market share of Gastrointestinal Cancer Drugs, for each region, from 2013 to 2018;
      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
      Chapter 12, Gastrointestinal Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
      Chapter 13, 14 and 15, to describe Gastrointestinal Cancer Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

      Buy now